Target intelligence / Profile preview

Iron mobilization and incorporation into heme

Molecular classification
Other, Metabolic pathway
01

Overview

Iron mobilization and incorporation into heme is a multi-step biological process essential for the production of hemoproteins such as hemoglobin, myoglobin, and cytochromes [StatPearls, 2023]. The process begins with the mobilization of iron from intracellular stores like ferritin or extracellular transport via transferrin, followed by its delivery to the mitochondrial matrix [NIH, 2022]. The final and rate-limiting step of heme biosynthesis is the incorporation of ferrous iron (Fe2+) into the protoporphyrin IX ring, a reaction catalyzed by the mitochondrial enzyme ferrochelatase (FECH) [UniProt P22392]. This pathway is tightly regulated to maintain iron homeostasis and prevent the accumulation of toxic free iron or porphyrin intermediates [PubMed PMID: 21865125]. Clinical disorders associated with this process include iron-deficiency anemia, where iron is scarce, and various porphyrias, which result from enzymatic defects in the heme synthesis chain [StatPearls, 2023]. Therapeutic strategies often involve iron supplementation with agents like ferrous sulfate, iron chelation therapy using deferoxamine to treat overload, or the management of environmental inhibitors like lead [PubChem, 2024]. Proper functioning of this pathway is critical for erythropoiesis and cellular respiration across all aerobic organisms [NIH, 2022].

Other names
Heme biosynthesis pathwayIron-heme metabolismProtoporphyrin IX iron-complex metabolic processHeme synthesis pathway
02

Mechanism of action

The pathway is modulated by providing iron substrates (e.g., ferrous sulfate), removing excess iron via chelation (e.g., deferoxamine), or through the inhibition of key enzymes like ferrochelatase by heavy metals such as lead [StatPearls, 2023; PubChem, 2024].

03

Biological functions

OtherHeme biosynthesisIron homeostasisErythropoiesis
04

Disease associations

OtherIron-deficiency anemiaErythropoietic protoporphyriaSideroblastic anemiaHemochromatosisLead poisoning
05

Safety considerations

Systemic iron toxicity [NIH, 2022]Oxidative tissue damage [PubMed PMID: 21865125]Cutaneous photosensitivity [StatPearls, 2023]Neurotoxicity [StatPearls, 2023]
06

Interacting drugs

Ferrous sulfate [PubChem, 2024]

4 more in the full profile.

07

Biomarkers

Serum ferritin [NIH, 2022]Transferrin saturation [NIH, 2022]Zinc protoporphyrin [PubMed PMID: 21865125]Hemoglobin [StatPearls, 2023]

Beyond the preview

Go deeper on Iron mobilization and incorporation into heme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron mobilization and incorporation into heme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call